you are viewing a single comment's thread.
so whats your point? What do short shares have to do with anything, last I looked Sepracor was trading mid $50s down from a big run to $61, NBIX is trading at $10 down from $73, so what is your point. The P2 pipeline Insomnia drug made it a get out of town decision for Pfizer to drop Indiplon. lots of unknows about 15Mg as their is no longterm trial data. long slogg to market if ever.Minor adverse event according to the FDA site.all Adverse events no matter how minor from a clinical trial is on the public record and placed in the label. Again what is your point?go back to sleep.